Vacancy for M.Pharm, M.Sc to wotk in Regulatory Affairs at Apotex
Apotex is a proudly Canadian, global pharmaceutical company that produces high-quality, affordable medicines (both generic and innovative pharmaceuticals) for patients around the world. We are the 7th largest generic pharmaceutical company globally with more than 12,000 employees and estimated sales of approximately $3 billion. Our fully integrated operation is comprised of four lines of business: Global Generics; Apobiologix; Global Active Pharmaceutical Ingredients (API); and ApoPharma (Innovative Products). With our worldwide manufacturing sites, Apotex can produce up to 24 billion dosages per year. We produce 300 medicines in 4,000 dosages and formats that are exported to 115 countries. Apotex will spend $2 billion over the next 10 years on research and development.
Post : Sr. Associate/Associate-Regulatory Affairs

Translational Health Science and Technology Institute (THSTI) is an autonomous Institute of the Department of Biotechnology, Ministry of Science and Technology, Govt, of India. The institute is an integral part of the interdisciplinary NCR Biotech Science Cluster located at Faridabad, and is designed as a dynamic, interactive organization with the mission to conduct innovative translational research and to develop research collaborations across disciplines and professions to translate concepts into tangible products to improve human health.THSTI has set up niche centres for research in areas relevant to planned translational work. They are: Vaccine and Infectious Disease Research Centre (VIDRC), Paediatric Biology Centre (PBC), Centre for Bio-design& Diagnostics (CBD), Drug Discovery Research Centre (DDRC), Centre for Human Microbial Ecology (CHME) and Policy Centre for Biomedical Research (PCBR). Clinical Development Services Agency (CDSA) and National Bio-design Alliance (NBA) are THSTI’s extramural centres.
Glenmark is a leading player in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity) with eight molecules in various stages of clinical development. The company has a significant presence in branded generics markets across emerging economies including India. Its subsidiary, Glenmark Generics Limited has a fast growing and robust US generics business. The subsidiary also markets APIs to regulated and semi-regulated countries. Glenmark employs nearly 6000 people in over 80 countries. It has twelve manufacturing facilities in four countries and has five R&D centres.
Institute of Life Sciences (ILS) was established in the year 1989 as an autonomous institute under the administrative control of Govt. of Odisha. In 2002, it was taken over by the Department of Biotechnology, Govt. of India. The Prime Minister of India Shri Atal Bihari Vajpayee dedicated the institute to the nation in July 2003. Institute of Life Sciences has a broad vision of carrying out high-quality multidisciplinary research in the area of life sciences. The goal is for overall development and betterment of human health, longevity, agriculture and environment. The stated mission of the institution is to work towards upliftment of the human society and generate skilled human resources for future India.
The National Institute of Immunology (NII) is an autonomous institution supported by the Department of Biotechnology, Government of India. The Institute is committed to advanced research addressing the basic mechanisms involved in body's defense, host-pathogen interactions and related areas with a view to contribute to the creation of an internationally competitive intellectual knowledge base as a sustainable source of innovative futuristic modalities of potential use in health care.
The Indian National Science Academy (INSA) was established in January 1935 with the object of promoting science in India and harnessing scientific knowledge for the cause of humanity and national welfare. The foundation of the Academy, earlier known as the National Institute of Sciences of India (NISI), was the outcome of joint endeavours of several organizations and individuals and the Indian Science Congress Association (ISCA) playing a leading role in this regard.
The Indian Institute of Technology Kanpur was established in the year 1960. The Parliament of India passed the ‘Institutes of Technology Act 1961’ declaring all the IITs as “Institutions of National Importance”. The Parliamentary Act has given absolute autonomy to the IITs. When the foundation stone of the IIT system was laid, it was perceived that taking help from the industrially advanced western countries might be lot more effective in achieving the status of a world class technical institute. Hence, IIT Kanpur had a massive collaboration with USA through a specially created programme- KIAP (Kanpur Indo American Programme).
A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

